Background COVID-19 (SARS-CoV-2/2019-nCoV) is now a major public health threat to the world. Olfactory dysfunctions (ODs) are considered potential indicating symptoms and early case identification triaging for coronavirus disease 2019 (COVID-19). The most common reported comorbidities are diabetes mellitus, chronic lung disease, and cardiovascular disease. The objective of this study was to evaluate prevalence of different types of smell disorders in patients with laboratory-confirmed COVID-19 infection and impact of involved systemic diseases. Methodology A cross-sectional retrospective study has been done for patients with laboratory-confirmed COVID-19 infection (mild-to-moderate). The data collected from patient’s files and developed online electronic questionnaire (WhatsApp) based on the patients most common and recurrent reported data including: a) symptoms of olfactory dysfunction and associated covid19 symptoms fever and headache, cough, sore throat, pneumonia, nausea, vomiting and diarrhea, arthralgia and myalgia and taste dysfunction. b) Associated systemic diseases including: diabetes, hypertension, asthma, chronic renal disease, chorionic liver disease and hypothyroidism. Results Of 308 patients confirmed with Covid-19 infection, (72.4%) developed OD distributed as follows; complete anosmia (57.8%), troposmia (8.4%), hyposmia (2.9%), partial anosmia (2.6%) and euosmia (0.6%). Significantly increased prevalence of diabetes, hypertension asthma in the group with olfactory dysfunction (p < 0.001), chronic liver disease (p = 0.005), and hypothyroidism (p = 0.03). Conclusion The development of ODs after Covid-19 infection was associated with mild disease form and lower hospitalization. In addition, it showed significant relationship with preexisting systemic diseases. Anosmia is the common modality of ODs.
Purpose: Obstructive sleep apnea (OSA) is a common sleep disorder that causes upper airway collapse leading to sleep apnea or hypopnea and is associated with serious health conditions. Despite being prevalent, it is an underdiagnosed and undertreated disease. We aimed at measuring the prevalence of OSA risk and detecting the level of knowledge of OSA among Egyptians attending outpatient clinics. Methods: A cross sectional study conducted at two university hospitals at Cairo using a Berlin questionnaire and OSA Knowledge and Attitude Questionnaire (OSAKA) Participants were recruited from outpatient clinics of Al-Hussein University Hospital and Al-Sayed Galal University Hospital. We used a validated Arabic translated version of the Berlin Questionnaire. Three domains (10 questions) were tested: the presence and severity of snoring, frequency of daytime sleepiness, and the presence of obesity or hypertension. A translation of 5 questions from OSA Knowledge/Attitude Questionnaire (OSAKA) that are suitable for the general population were also used. Results: Out of 395 participants approached, 345 participants (87%) completed the questionnaire. The age ranged from 18 to 82 years old (40.9 ± 15.5 SD). About 52% of participants were females (n=179) and 48% were males (n=166). The prevalence of high risk OSA among the studied population was 17.4% (n=60). Older ages, obesity and hypertension were found to be significantly associated with OSA risk. On the level of OSA awareness, 90.1% (n=311) of participants didn’t not have previous knowledge about OSA and there was no significant association between participants’ knowledge, and risk of OSA. Conclusion: Obstructive sleep apnea (OSA) was associated with older ages, obesity and hypertension. The knowledge level was far from needed among the studied group. This lack of knowledge needs to be addressed to reduce the underdiagnosis and undertreatment of obstructive sleep apnea.
Introduction: Obstructive sleep apnea (OSA) is a common sleep disorder that causes upper airway collapse, leading to sleep apnea or hypopnea, and is associated with serious health conditions. Despite its prevalence, it is an underdiagnosed and undertreated disease. We aimed to measure the prevalence of OSA risk and detect the level of knowledge of OSA among Egyptians attending outpatient clinics. Methods: A cross-sectional study was conducted at two university hospitals in Cairo using the Berlin Questionnaire and OSA Knowledge and Attitude Questionnaire (OSAKA). The participants were recruited from the outpatient clinics of Al-Hussein University Hospital and Al-Sayed Galal University Hospital. We used a validated Arabic translated version of the Berlin Questionnaire. Ten questions across three domains were tested: the presence and severity of snoring, frequency of daytime sleepiness, and presence of obesity or hypertension. A translation of five questions from (OSAKA) deemed suitable for the general population, was also used. Results: Out of 395 participants, 345 (87%) completed the questionnaire. The participants’ ages ranged from 18 to 82 years old (40.9 ± 15.5 SD). Approximately 52% of the participants were female (n = 179) and 48% were male (n = 166). The prevalence of high risk OSA among the studied population was 17.4% (n = 60). Older age and obesity were found to be significantly associated with OSA risk. In terms of OSA awareness, 90.1% (n = 311) of the participants did not have previous knowledge of OSA, and there was no significant association between the participants’ knowledge and risk of OSA. Conclusion: OSA was associated with older age and obesit. Knowledge level was far from needed among the studied group. This lack of knowledge needs to be addressed to reduce the underdiagnosis and undertreatment of OSA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.